Zydus, Apollo partner on cancer detection test: Key Highlights | TheBriefWire
Zydus, Apollo partner on cancer detection test
Published 3 July 2026 ยท health
Synopsis Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health
Synopsis Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.
Published: July 3, 2026 โข 2:30 PM IST ยท Updated: July 3, 2026 โข 3:07 PM ISTBy TheBriefWire Editorial Team
Key points
Synopsis Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health.
This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above.
The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.